US president of health responds to new coronal vaccine obtained before November: not likely to be approved

Francis Collins, President of the National Institutes of Health (NIH), said on Thursday that any potential new crown vaccine supported by Trump’s “operation warp speed” is unlikely to be approved by regulators before November or December, considering the time required for large-scale clinical trials. According to Collins, testing one vaccine in at least 10000 people is likely to provide sufficient evidence of safety and efficacy and lay the foundation for wide-scale promotion. It is reported that the United States is currently launching a late vaccine trial aimed at recruiting up to 30000 people. Trump said last week that the United States could have a new crown vaccine before the November 3 election, a more optimistic forecast in terms of time than any of his own white house health experts have suggested.